News
New Clinical Trial Option For Dogs With Malignant Tumors |
03/02/2010
New England Veterinary Oncology Group is pleased to announce participation and active solicitation for cases to enroll in a clinical trial to evaluate a novel anti-cancer therapy. The study is designed into two phases. The initial phase will evaluate the safety of this drug in dogs with any measurable cancer (excluding hemangiosarcoma). The second phase will evaluate he safety of this drug in dogs with hemangiosarcoma exclusively. No placebo is used.
New England Veterinary Oncology Group is pleased to announce participation and active solicitation for cases to enroll in a clinical trial to evaluate a novel anti-cancer therapy. The study is designed into two phases. The initial phase will evaluate the safety of this drug in dogs with any measurable cancer (excluding hemangiosarcoma). The second phase will evaluate he safety of this drug in dogs with hemangiosarcoma exclusively. No placebo is used.
2010 Office Hour Changes |
03/02/2010
At times it is necessary for us to make adjustments to our scheduled hours. When we need to make changes we will post them on our web site.
At times it is necessary for us to make adjustments to our scheduled hours. When we need to make changes we will post them on our web site.
Palladia, the new drug from Pfizer. |
07/22/2009
There has been much buzz and excitement surrounding FDA approval of Palladia (Pfizer), which is new drug licensed for treatment of mast cell tumors in dogs. Palladia is in the family of drugs called tyrosine kinase inhibitors which have been used in the treatment of cancer in humans for many years. Not only does Palladia provide veterinarians with a novel way to treat some of the more difficult mast cell tumors, it represents a commitment from drug companies like Pfizer to developing therapies specific for our veterinary cancer patients. Palladia is currently available only through veterinary oncologists and other selected specialists.
There has been much buzz and excitement surrounding FDA approval of Palladia (Pfizer), which is new drug licensed for treatment of mast cell tumors in dogs. Palladia is in the family of drugs called tyrosine kinase inhibitors which have been used in the treatment of cancer in humans for many years. Not only does Palladia provide veterinarians with a novel way to treat some of the more difficult mast cell tumors, it represents a commitment from drug companies like Pfizer to developing therapies specific for our veterinary cancer patients. Palladia is currently available only through veterinary oncologists and other selected specialists.
N.E.V.O.G. is now seeing patients in Newington, NH and Woburn, MA (05/05/09) |
04/26/2009
The New England Veterinary Oncology Group LLP (NEVOG) the only private, full service, veterinary oncology care center in New England based in Waltham MA, is now seeing patients in New Hampshire at the Veterinary Emergency, Critical Care and Cancer Center of NH in Newington and Massachusetts Veterinary Referral Hospital in Woburn, MA. Drs. Kim Cronin, Jeff Philibert, Erin Romansik and Sheri Siegel bring to the Newington and Woburn offices the same high quality and compassionate care for which NEVOG is known.
The New England Veterinary Oncology Group LLP (NEVOG) the only private, full service, veterinary oncology care center in New England based in Waltham MA, is now seeing patients in New Hampshire at the Veterinary Emergency, Critical Care and Cancer Center of NH in Newington and Massachusetts Veterinary Referral Hospital in Woburn, MA. Drs. Kim Cronin, Jeff Philibert, Erin Romansik and Sheri Siegel bring to the Newington and Woburn offices the same high quality and compassionate care for which NEVOG is known.
Emergency on call for active patients |
08/21/2008
NEVOG is pleased to announce that we are now offering an on-call after hours emergency service. The goal of this service is to help make recommendations in emergency situations. A NEVOG clinician will be available by phone to offer advice and if needed, direct you to the appropriate emergency facility. We will also be able to consult with an emergency clinician if it is recommended that your pet be seen.
NEVOG is pleased to announce that we are now offering an on-call after hours emergency service. The goal of this service is to help make recommendations in emergency situations. A NEVOG clinician will be available by phone to offer advice and if needed, direct you to the appropriate emergency facility. We will also be able to consult with an emergency clinician if it is recommended that your pet be seen.
Pet Friendly Hotels |
11/23/2007
We are often asked if there are pet friendly hotels in the area. While we do know of some hotels that are designated as pet friendly our list is not 100% comprehensive.
We are often asked if there are pet friendly hotels in the area. While we do know of some hotels that are designated as pet friendly our list is not 100% comprehensive.
Dr. Erin M. Romansik